Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 Nov 1;176(5):1483–1487. doi: 10.1084/jem.176.5.1483

Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens [published erratum appears in J Exp Med 1993 Feb 1;177(2):following 576]

PMCID: PMC2119424  PMID: 1383389

Abstract

Immune responses in major histocompatibility complex (MHC)-disparate congenic mouse strains immunized with sexual stage malaria parasites or purified recombinant protein were adjuvant dependent. Whereas mice exhibited a limited antibody response to immunization with newly emerged Plasmodium falciparum gametes in Freund's adjuvant, all five congenic mouse strains responded to several transmission-blocking vaccine candidate antigens, when parasites were emulsified in a monophosphoryl lipid A (MPL) and trehalose dimycolate (TDM) adjuvant. The humoral response in those animals immunized with the antigen in a MPL/TDM adjuvant was helper T cell dependent, as evident by boosting of the antibody response after a second immunization. If the immunogen consisted of purified recombinant protein, then the immune response was not MHC class II limited in mice immunized with either complete Freund's adjuvant or TDM/MPL. The potential role of adjuvants in overcoming apparent immune nonresponsiveness and the implications for development of a malaria transmission-blocking vaccine are discussed.

Full Text

The Full Text of this article is available as a PDF (730.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azuma I., Ribi E. E., Meyer T. J., Zbar B. Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J Natl Cancer Inst. 1974 Jan;52(1):95–101. doi: 10.1093/jnci/52.1.95. [DOI] [PubMed] [Google Scholar]
  2. Baker P. J., Fauntleroy M. B., Stashak P. W., Hiernaux J. R., Cantrell J. L., Rudbach J. A. Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide. Infect Immun. 1989 Mar;57(3):912–917. doi: 10.1128/iai.57.3.912-917.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baker P. J., Hiernaux J. R., Fauntleroy M. B., Prescott B., Cantrell J. L., Rudbach J. A. Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A. Infect Immun. 1988 May;56(5):1076–1083. doi: 10.1128/iai.56.5.1076-1083.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carter R., Graves P. M., Quakyi I. A., Good M. F. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. J Exp Med. 1989 Jan 1;169(1):135–147. doi: 10.1084/jem.169.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carter R., Kumar N., Quakyi I., Good M., Mendis K., Graves P., Miller L. Immunity to sexual stages of malaria parasites. Prog Allergy. 1988;41:193–214. [PubMed] [Google Scholar]
  6. Del Giudice G., Cooper J. A., Merino J., Verdini A. S., Pessi A., Togna A. R., Engers H. D., Corradin G., Lambert P. H. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines. J Immunol. 1986 Nov 1;137(9):2952–2955. [PubMed] [Google Scholar]
  7. Dontfraid F., Cochran M. A., Pombo D., Knell J. D., Quakyi I. A., Kumar S., Houghten R. A., Berzofsky J. A., Miller L. H., Good M. F. Human and murine CD4 T cell epitopes map to the same region of the malaria circumsporozoite protein: limited immunogenicity of sporozoites and circumsporozoite protein. Mol Biol Med. 1988 Dec;5(3):185–196. [PubMed] [Google Scholar]
  8. Good M. F., Berzofsky J. A., Maloy W. L., Hayashi Y., Fujii N., Hockmeyer W. T., Miller L. H. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med. 1986 Aug 1;164(2):655–660. doi: 10.1084/jem.164.2.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Good M. F., Miller L. H., Kumar S., Quakyi I. A., Keister D., Adams J. H., Moss B., Berzofsky J. A., Carter R. Limited immunological recognition of critical malaria vaccine candidate antigens. Science. 1988 Oct 28;242(4878):574–577. doi: 10.1126/science.2902690. [DOI] [PubMed] [Google Scholar]
  10. Good M. F., Pombo D., Lunde M. N., Maloy W. L., Halenbeck R., Koths K., Miller L. H., Berzofsky J. A. Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2. J Immunol. 1988 Aug 1;141(3):972–977. [PubMed] [Google Scholar]
  11. Good M. F., Pombo D., Maloy W. L., de la Cruz V. F., Miller L. H., Berzofsky J. A. Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite protein. J Immunol. 1988 Mar 1;140(5):1645–1650. [PubMed] [Google Scholar]
  12. Grand-Perret T., Lepoivre M., Petit J. F., Lemaire G. Macrophage activation by trehalose dimycolate requirement for an expression signal in vitro for antitumoral activity; biochemical markers distinguishing primed and fully activated macrophages. Eur J Immunol. 1986 Apr;16(4):332–338. doi: 10.1002/eji.1830160403. [DOI] [PubMed] [Google Scholar]
  13. Graves P. M., Bhatia K., Burkot T. R., Prasad M., Wirtz R. A., Beckers P. Association between HLA type and antibody response to malaria sporozoite and gametocyte epitopes is not evident in immune Papua New Guineans. Clin Exp Immunol. 1989 Dec;78(3):418–423. [PMC free article] [PubMed] [Google Scholar]
  14. Graves P. M., Carter R., Burkot T. R., Quakyi I. A., Kumar N. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol. 1988 Mar;10(2):209–218. doi: 10.1111/j.1365-3024.1988.tb00215.x. [DOI] [PubMed] [Google Scholar]
  15. Hui G. S., Chang S. P., Gibson H., Hashimoto A., Hashiro C., Barr P. J., Kotani S. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. J Immunol. 1991 Dec 1;147(11):3935–3941. [PubMed] [Google Scholar]
  16. Hui G. S., Tam L. Q., Chang S. P., Case S. E., Hashiro C., Siddiqui W. A., Shiba T., Kusumoto S., Kotani S. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. Infect Immun. 1991 May;59(5):1585–1591. doi: 10.1128/iai.59.5.1585-1591.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ifediba T., Vanderberg J. P. Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature. 1981 Nov 26;294(5839):364–366. doi: 10.1038/294364a0. [DOI] [PubMed] [Google Scholar]
  18. Kabilan L., Troye-Blomberg M., Perlmann H., Andersson G., Högh B., Petersen E., Björkman A., Perlmann P. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5659–5663. doi: 10.1073/pnas.85.15.5659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kaslow D. C. Immunogenicity of Plasmodium falciparum sexual stage antigens: implications for the design of a transmission blocking vaccine. Immunol Lett. 1990 Aug;25(1-3):83–86. doi: 10.1016/0165-2478(90)90096-9. [DOI] [PubMed] [Google Scholar]
  20. Kawamura H., Rosenberg S. A., Berzofsky J. A. Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness. J Exp Med. 1985 Jul 1;162(1):381–386. doi: 10.1084/jem.162.1.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lemaire G., Tenu J. P., Petit J. F., Lederer E. Natural and synthetic trehalose diesters as immunomodulators. Med Res Rev. 1986 Jul-Sep;6(3):243–274. doi: 10.1002/med.2610060302. [DOI] [PubMed] [Google Scholar]
  22. Lew A. M., Langford C. J., Pye D., Edwards S., Corcoran L., Anders R. F. Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia. J Immunol. 1989 Jun 1;142(11):4012–4016. [PubMed] [Google Scholar]
  23. Nijhout M. M. Plasmodium gallinaceum: exflagellation stimulated by a mosquito factor. Exp Parasitol. 1979 Aug;48(1):75–80. doi: 10.1016/0014-4894(79)90056-0. [DOI] [PubMed] [Google Scholar]
  24. Quakyi I. A., Otoo L. N., Pombo D., Sugars L. Y., Menon A., De Groot A. S., Johnson A., Alling D., Miller L. H., Good M. F. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens. Am J Trop Med Hyg. 1989 Aug;41(2):125–134. [PubMed] [Google Scholar]
  25. Rawlings D. J., Kaslow D. C. A novel 40-kDa membrane-associated EF-hand calcium-binding protein in Plasmodium falciparum. J Biol Chem. 1992 Feb 25;267(6):3976–3982. [PubMed] [Google Scholar]
  26. Rener J., Graves P. M., Carter R., Williams J. L., Burkot T. R. Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum. J Exp Med. 1983 Sep 1;158(3):976–981. doi: 10.1084/jem.158.3.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ribi E. Beneficial modification of the endotoxin molecule. J Biol Response Mod. 1984;3(1):1–9. [PubMed] [Google Scholar]
  28. Rickman L. S., Gordon D. M., Wistar R., Jr, Krzych U., Gross M., Hollingdale M. R., Egan J. E., Chulay J. D., Hoffman S. L. Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet. 1991 Apr 27;337(8748):998–1001. doi: 10.1016/0140-6736(91)92659-p. [DOI] [PubMed] [Google Scholar]
  29. Tomlinson L. A., Christie J. F., Fraser E. M., McLaughlin D., McIntosh A. E., Kennedy M. W. MHC restriction of the antibody repertoire to secretory antigens, and a major allergen, of the nematode parasite Ascaris. J Immunol. 1989 Oct 1;143(7):2349–2356. [PubMed] [Google Scholar]
  30. Vermeulen A. N., Ponnudurai T., Beckers P. J., Verhave J. P., Smits M. A., Meuwissen J. H. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med. 1985 Nov 1;162(5):1460–1476. doi: 10.1084/jem.162.5.1460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Walliker D., Quakyi I. A., Wellems T. E., McCutchan T. F., Szarfman A., London W. T., Corcoran L. M., Burkot T. R., Carter R. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science. 1987 Jun 26;236(4809):1661–1666. doi: 10.1126/science.3299700. [DOI] [PubMed] [Google Scholar]
  32. de la Cruz V. F., Lal A. A., McCutchan T. F. Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development. J Biol Chem. 1987 Sep 5;262(25):11935–11939. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES